LEMD2
Basic information
Region (hg38): 6:33771202-33789130
Links
Phenotypes
GenCC
Source:
- cataract 46 juvenile-onset (Limited), mode of inheritance: AR
- total early-onset cataract (Supportive), mode of inheritance: AD
- early-onset posterior subcapsular cataract (Supportive), mode of inheritance: AD
- cataract 46 juvenile-onset (Strong), mode of inheritance: AR
- cataract 46 juvenile-onset (Limited), mode of inheritance: AR
- Marbach-Rustad progeroid syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Marbach-Rustad progeroid syndrome; Cataract 46, juvenile onset, with or without arrhthythmic cardiomyopathy | AD/AR | Cardiovascular; Endocrine | Individuals with Marbach-Rustad progeroid syndrome have been described with cardiac manifestations, and awareness may allow early diagnosis and management; Individuals with Marbach-Rustad progeroid syndrome have been described as receiving treatment with growth hormone therapy; In Cataract 46, juvenile onset, with or without arrhthythmic cardiomyopathy, individuals have been described with cardiovascular manifestations including arrhythmic cardiomyopathy and sudden cardiac death, and awareness may allow early diagnosis and management; Heart transplant has been described | Cardiovascular; Dental; Endocrine; Neurologic; Ophthalmologic | 23863954; 26788539; 30905398; 31061923 |
ClinVar
This is a list of variants' phenotypes submitted to
- Cataract 46 juvenile-onset (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LEMD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 29 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 16 | 17 | ||||
Total | 1 | 1 | 29 | 9 | 22 |
Variants in LEMD2
This is a list of pathogenic ClinVar variants found in the LEMD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-33772548-G-C | Benign (May 12, 2021) | |||
6-33772605-G-A | Benign (May 12, 2021) | |||
6-33772638-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
6-33772704-G-A | 19 conditions • Marbach-Rustad progeroid syndrome | Conflicting classifications of pathogenicity (Jun 14, 2023) | ||
6-33772710-G-A | Cataract 46 juvenile-onset • not specified | Uncertain significance (Jan 26, 2022) | ||
6-33772727-G-A | LEMD2-related disorder | Likely benign (May 22, 2019) | ||
6-33772774-G-A | not specified | Uncertain significance (Nov 22, 2022) | ||
6-33772790-G-A | Likely benign (Jul 19, 2022) | |||
6-33772815-C-T | Benign (May 12, 2021) | |||
6-33772927-AGAG-A | Benign (May 13, 2021) | |||
6-33776934-C-T | Benign (Jan 27, 2024) | |||
6-33776945-G-A | Benign (Jan 15, 2024) | |||
6-33777037-G-A | Benign/Likely benign (Dec 01, 2023) | |||
6-33777103-G-A | Benign (May 13, 2021) | |||
6-33777105-C-G | Benign (May 12, 2021) | |||
6-33777134-G-A | LEMD2-related disorder | Likely benign (Dec 07, 2023) | ||
6-33777182-T-C | Uncertain significance (Nov 18, 2023) | |||
6-33777197-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
6-33777205-T-C | Likely benign (Dec 17, 2022) | |||
6-33777294-C-T | Benign (May 12, 2021) | |||
6-33778314-G-A | Uncertain significance (Sep 27, 2022) | |||
6-33778319-T-C | Uncertain significance (Jun 09, 2022) | |||
6-33778343-T-C | not specified | Uncertain significance (Mar 20, 2024) | ||
6-33778366-A-T | LEMD2-related disorder | Likely benign (Oct 28, 2019) | ||
6-33780110-C-T | not specified | Uncertain significance (Dec 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LEMD2 | protein_coding | protein_coding | ENST00000293760 | 9 | 17935 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.753 | 0.247 | 125735 | 0 | 12 | 125747 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 157 | 235 | 0.667 | 0.0000134 | 3121 |
Missense in Polyphen | 55 | 88.621 | 0.62062 | 979 | ||
Synonymous | 0.813 | 88 | 98.3 | 0.896 | 0.00000531 | 1077 |
Loss of Function | 3.58 | 4 | 22.2 | 0.180 | 0.00000121 | 258 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000617 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000890 | 0.0000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in nuclear structure organization (PubMed:16339967). Required for maintaining the integrity of the nuclear envelope (PubMed:17097643). {ECO:0000269|PubMed:16339967, ECO:0000269|PubMed:17097643}.;
- Pathway
- Clearance of Nuclear Envelope Membranes from Chromatin;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.121
Haploinsufficiency Scores
- pHI
- 0.223
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.757
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lemd2
- Phenotype
- growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- nuclear envelope organization;neurogenesis;negative regulation of BMP signaling pathway;skeletal muscle cell differentiation;negative regulation of MAPK cascade;negative regulation of protein kinase B signaling;heart formation;protein localization to chromatin
- Cellular component
- chromatin;nuclear envelope;nuclear inner membrane;integral component of nuclear inner membrane;endoplasmic reticulum;membrane;integral component of membrane;nuclear membrane
- Molecular function
- protein binding